NFKB1 and prostate carcinoma: This process, in turn, suppresses the nuclear factor-κB (NF-κB)-mediated transcriptional activation, thereby reducing the production of interleukin 8 (IL-8) and limiting the proliferation of prostate cancer cells [28].